agilon health, inc.
AGL
$0.43
-$0.01-2.39%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.57B | 1.43B | 1.39B | 1.53B | 1.52B |
| Total Other Revenue | 2.51M | 2.88M | 2.94M | 2.90M | 3.24M |
| Total Revenue | 1.57B | 1.44B | 1.39B | 1.53B | 1.52B |
| Cost of Revenue | 1.66B | 1.50B | 1.45B | 1.48B | 1.56B |
| Gross Profit | -90.67M | -67.65M | -52.43M | 50.72M | -38.26M |
| SG&A Expenses | 58.76M | 52.11M | 56.16M | 65.43M | 59.91M |
| Depreciation & Amortization | 6.97M | 7.43M | 7.32M | 6.88M | 6.49M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.73B | 1.56B | 1.51B | 1.55B | 1.63B |
| Operating Income | -156.40M | -127.18M | -115.91M | -21.59M | -104.66M |
| Income Before Tax | -187.56M | -110.54M | -104.31M | -1.69M | -104.67M |
| Income Tax Expenses | 1.32M | -331.00K | 62.00K | 196.00K | 1.76M |
| Earnings from Continuing Operations | -188.88M | -110.21M | -104.37M | -1.89M | -106.43M |
| Earnings from Discontinued Operations | 0.00 | -- | -- | 14.00M | 640.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | 0.00 |
| Net Income | -188.88M | -110.21M | -104.37M | 12.11M | -105.79M |
| EBIT | -156.40M | -127.18M | -115.91M | -21.59M | -104.66M |
| EBITDA | -152.68M | -119.75M | -108.59M | -14.71M | -98.17M |
| EPS Basic | -0.46 | -0.27 | -0.25 | 0.03 | -0.26 |
| Normalized Basic EPS | -0.23 | -0.16 | -0.16 | 0.00 | -0.15 |
| EPS Diluted | -0.46 | -0.27 | -0.25 | 0.03 | -0.26 |
| Normalized Diluted EPS | -0.23 | -0.16 | -0.16 | 0.00 | -0.15 |
| Average Basic Shares Outstanding | 414.62M | 414.47M | 413.84M | 412.94M | 412.04M |
| Average Diluted Shares Outstanding | 414.62M | 414.47M | 413.84M | 412.94M | 412.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |